Published in Am J Surg on October 01, 1995
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg (2008) 2.38
The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer (2005) 1.69
A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol (2010) 1.41
Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer (2010) 1.31
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer (2007) 1.21
C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci (2004) 1.14
Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer (2004) 1.14
Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today (2008) 1.11
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma. J Transl Med (2014) 1.02
The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. Br J Cancer (2006) 1.00
Surgery for colorectal liver metastases: The evolution of determining prognosis. World J Gastrointest Oncol (2013) 0.95
The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer. Br J Cancer (2003) 0.92
Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery. Dig Dis Sci (2015) 0.89
A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients. Support Care Cancer (2007) 0.87
Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med (2010) 0.86
A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev (2014) 0.86
The effect of obstruction and perforation on colorectal cancer disease-free survival. World J Surg (2010) 0.83
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma. J Surg Oncol (2015) 0.80
Perioperative host-tumor inflammatory interactions: a potential trigger for disease recurrence following a curative resection for colorectal cancer. Surg Today (2008) 0.79
Remodeling of the immunoinflammatory network system in elderly cancer patients: implications of inflamm-aging and tumor-specific hyperinflammation. Surg Today (2008) 0.78
Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy. ISRN Gastroenterol (2013) 0.77
Role for gender in colorectal cancer risk: a Taiwan population-based study. Int J Colorectal Dis (2013) 0.77
Gender differences in colorectal cancer survival in Japan. Int J Clin Oncol (2015) 0.76
Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer. Onco Targets Ther (2015) 0.75
Expression of C-Reactive Protein in Rectal Cancer. Gastroenterology Res (2009) 0.75
Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg (2003) 6.04
Psychological support for patients undergoing breast cancer surgery: a randomised study. BMJ (1996) 4.11
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer (2003) 3.44
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer (2002) 2.80
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet (1996) 2.78
Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg (1994) 2.69
Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer (2000) 2.50
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer (2004) 2.39
Outcome of patients with abdominal sepsis treated in an intensive care unit. Br J Surg (1995) 2.38
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer (2007) 2.36
Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics. Br Med J (1979) 2.15
Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer (2001) 2.10
Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer (1995) 2.09
Prediction of risk in biliary surgery. Br J Surg (1983) 2.07
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. J Natl Cancer Inst (1987) 2.02
Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg (2001) 1.96
Proceedings: Comparison of a coronary vasodilator drug (carbochromen) and a cardiac stimulant (oxyfedrin) on blood flow and oxygen extraction in experimental myocardial infarcts. Br J Pharmacol (1972) 1.94
Occult hepatic metastases in colorectal carcinoma. Br J Surg (1986) 1.90
Evaluating HER2 amplification and overexpression in breast cancer. J Pathol (2001) 1.89
Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer (1998) 1.88
Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis. Br J Surg (2000) 1.87
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer (2003) 1.86
Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer (2001) 1.80
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol (2001) 1.79
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol (2009) 1.78
Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) (2000) 1.74
An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer (2005) 1.71
The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer (2005) 1.69
Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg (2007) 1.62
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res (1993) 1.58
Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet (2000) 1.58
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer (1996) 1.57
Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg (1988) 1.55
Effects of a somatostatin analogue (SMS 201-995) on the growth and development of hepatic tumour derived by intraportal injection of Walker cells in the rat. Br J Surg (1989) 1.55
Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer (1997) 1.52
Psychological impact of adjuvant chemotherapy in the first two years after mastectomy. Br Med J (Clin Res Ed) (1986) 1.51
Laparotomy for abdominal sepsis in the critically ill. Br J Surg (1996) 1.50
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. Ann Oncol (2008) 1.50
Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis. Crit Care Med (2001) 1.49
Transcutaneous electrical stimulation for postoperative pain. Ann R Coll Surg Engl (1985) 1.48
Adequate surgery for papillary thyroid cancer. Surgeon (2009) 1.48
Transient femoral nerve palsy complicating preoperative ilioinguinal nerve blockade for inguinal herniorrhaphy. Br J Surg (1994) 1.48
Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer (1994) 1.48
The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer (1999) 1.46
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer (2005) 1.46
Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer (1999) 1.45
Changes in the hepatic perfusion index during the development of experimental hepatic tumours. Br J Surg (1989) 1.45
Therapeutic implications of the sentinel lymph node in breast cancer. Lancet (1999) 1.45
Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology (1995) 1.45
The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia (1987) 1.44
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
The relationship between intraoperative contamination of the lower respiratory tract and postoperative chest infection. J Hosp Infect (1995) 1.40
Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg (2002) 1.39
Ketorolac trometamol for postoperative analgesia after orthopaedic surgery. Br J Anaesth (1992) 1.38
Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer (2007) 1.36
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition (1996) 1.34
Incidence and detection of occult hepatic metastases in colorectal carcinoma. Br Med J (Clin Res Ed) (1982) 1.31
Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut (1993) 1.31
Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer (1998) 1.31
Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma. Breast Cancer Res Treat (2003) 1.30
Prospective study of the treatment of septic shock. Lancet (1978) 1.27
The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer (2004) 1.27
The use of duplex sonography in the detection of colorectal hepatic metastases. Br J Cancer (1991) 1.27
Changes in hepatic haemodynamics and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats. Br J Surg (1991) 1.26
Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs. Br Med J (Clin Res Ed) (1985) 1.25
Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA (1995) 1.25
Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer. Clin Sci (Lond) (1999) 1.25
An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res (1994) 1.25
Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg (1996) 1.23
Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer (1999) 1.22
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer (2000) 1.22
Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol (1997) 1.21
Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. Br J Cancer (2007) 1.21
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer (2013) 1.21
Psychosocial effects of radiotherapy after mastectomy. Br Med J (Clin Res Ed) (1987) 1.20
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr (1998) 1.19
Detection of hepatic metastases using duplex/color Doppler sonography. Ann Surg (1991) 1.19
The incidence of the shock syndrome in a general hospital. Postgrad Med J (1974) 1.19
Doppler perfusion index: an interobserver and intraobserver reproducibility study. Radiology (1998) 1.18
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours. Br J Cancer (2009) 1.17
Cimetidine and peptic ulcer. Lancet (1981) 1.17
Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer (2007) 1.17
P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer (1990) 1.15
Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond) (1997) 1.15
A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer (2000) 1.15
The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. Br J Cancer (1991) 1.14
Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer (2004) 1.14
Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer. Eur J Surg Oncol (2004) 1.12
Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer (1987) 1.12
Evaluation of the prognostic factors in gastric cancer: the effect of chemotherapy on survival. Br J Surg (1987) 1.11
Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg (1996) 1.11
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer (1999) 1.11
Early detection of occult colorectal hepatic metastases using duplex colour Doppler sonography. Br J Surg (1993) 1.11
Role of carcinoembryonic antigen in detection of asymptomatic disseminated disease in colorectal carcinoma. Br Med J (Clin Res Ed) (1983) 1.10